Histological and prognostic importance of CD44+/CD24+/EpCAM+expression in clinical pancreatic cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histological and prognostic importance of CD44+/CD24+/EpCAM+expression in clinical pancreatic cancer
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 104, Issue 8, Pages 1127-1134
Publisher
Wiley
Online
2013-05-17
DOI
10.1111/cas.12198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target
- (2011) S Buczacki et al. BRITISH JOURNAL OF CANCER
- Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity
- (2011) H Akita et al. ONCOGENE
- Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM and ALDH1 in colorectal cancer
- (2010) A Lugli et al. BRITISH JOURNAL OF CANCER
- Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy
- (2010) James P. Sullivan et al. CANCER AND METASTASIS REVIEWS
- Cancer Stem Cell Tumor Model Reveals Invasive Morphology and Increased Phenotypical Heterogeneity
- (2010) A. Sottoriva et al. CANCER RESEARCH
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content
- (2010) Salvatore Pece et al. CELL
- IL-4-mediated drug resistance in colon cancer stem cells
- (2010) Matilde Todaro et al. CELL CYCLE
- Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
- (2010) S. Y. Park et al. CLINICAL CANCER RESEARCH
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- Characterization and functional analysis of a slow cycling stem cell-like subpopulation in pancreas adenocarcinoma
- (2009) Jennifer L. Dembinski et al. CLINICAL & EXPERIMENTAL METASTASIS
- Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer
- (2009) Maria–Theresa Mueller et al. GASTROENTEROLOGY
- Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
- (2009) Chun-Yan Li et al. Journal of Translational Medicine
- Cancer Stem Cells in Solid Tumors: An Overview
- (2009) Catherine Adell O'Brien et al. SEMINARS IN RADIATION ONCOLOGY
- Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
- (2008) Heike Immervoll et al. BMC CANCER
- CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
- (2008) L M Smith et al. BRITISH JOURNAL OF CANCER
- CD133 expression is an independent prognostic marker for low survival in colorectal cancer
- (2008) D Horst et al. BRITISH JOURNAL OF CANCER
- Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
- (2008) Zhen Fan Yang et al. CANCER CELL
- Recent advances in cancer stem cells
- (2008) Robert W Cho et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- The clinicopathologic and prognostic significance of CD44+/CD24−/low and CD44−/CD24+ tumor cells in invasive breast carcinomas
- (2008) Eleni Mylona et al. HUMAN PATHOLOGY
- Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
- (2008) X. Li et al. JNCI-Journal of the National Cancer Institute
- Isolation and biological analysis of tumor stem cells from pancreatic adenocarcinoma
- (2008) Peng Huang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now